Literature DB >> 20008131

Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction.

Toshihide Hara1, Kazuhiro Shimizu, Fumihide Ogawa, Koichi Yanaba, Yohei Iwata, Eiji Muroi, Motoi Takenaka, Kazuhiro Komura, Minoru Hasegawa, Manabu Fujimoto, Shinichi Sato.   

Abstract

Platelets have been shown to be important in inflammation, but their role in the cutaneous Arthus reaction remains unclear. To assess the role of platelets in this pathogenetic process, the cutaneous Arthus reaction was examined in wild-type mice and mice lacking E-selectin, P-selectin, or P-selectin glycoprotein ligand-1 (PSGL-1) with or without platelet depletion by busulfan, a bone marrow precursor cell-specific toxin. Edema and hemorrhage induced by immune complex challenge significantly decreased in busulfan-treated wild-type mice compared with untreated mice. Busulfan treatment did not affect edema and hemorrhage in P-selectin- or PSGL-1-deficient mice, suggesting that the effect by busulfan is dependent on P-selectin and PSGL-1 expression. The inhibited edema and hemorrhage paralleled reduced infiltration of neutrophils and mast cells and reduced levels of circulating platelets. Increased cutaneous production of interleukin-6, tumor necrosis factor-alpha, and platelet-derived chemokines during Arthus reaction was inhibited in busulfan-treated wild-type mice relative to untreated mice, which paralleled the reduction in cutaneous inflammation. Flow cytometric analysis showed that immune complex challenge generated blood platelet-leukocyte aggregates that decreased by busulfan treatment. In thrombocytopenic mice, the cutaneous inflammation after immune complex challenge was restored by platelet infusion. These results suggest that platelets induce leukocyte recruitment into skin by forming platelet-leukocyte aggregates and secreting chemokines at inflamed sites, mainly through the interaction of P-selectin on platelets with PSGL-1 on leukocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008131      PMCID: PMC2797888          DOI: 10.2353/ajpath.2010.081117

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  55 in total

Review 1.  Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity.

Authors:  E C Butcher
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

2.  Role of P-selectin and leukocyte activation in polymorphonuclear cell adhesion to surface adherent activated platelets under physiologic shear conditions (an injury vessel wall model).

Authors:  E L Yeo; J A Sheppard; I A Feuerstein
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

3.  Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity.

Authors:  P K Jeffery; A J Wardlaw; F C Nelson; J V Collins; A B Kay
Journal:  Am Rev Respir Dis       Date:  1989-12

Review 4.  Interleukin-6 in biology and medicine.

Authors:  S Akira; T Taga; T Kishimoto
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

5.  A monoclonal antibody to a membrane glycoprotein binds only to activated platelets.

Authors:  R P McEver; M N Martin
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

6.  A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets.

Authors:  S Hsu-Lin; C L Berman; B C Furie; D August; B Furie
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

7.  PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes.

Authors:  E Larsen; A Celi; G E Gilbert; B C Furie; J K Erban; R Bonfanti; D D Wagner; B Furie
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

8.  Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry.

Authors:  S J Shattil; M Cunningham; J A Hoxie
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

9.  Augmentation of reverse arthus reaction by mast cells in mice.

Authors:  Y Zhang; B F Ramos; B A Jakschik
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

10.  Targeted gene disruption demonstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration.

Authors:  J Yang; T Hirata; K Croce; G Merrill-Skoloff; B Tchernychev; E Williams; R Flaumenhaft; B C Furie; B Furie
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

View more
  20 in total

Review 1.  Platelet-leukocyte interactions in cardiovascular disease and beyond.

Authors:  Licia Totani; Virgilio Evangelista
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

Review 2.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

3.  Platelets docking to VWF prevent leaks during leukocyte extravasation by stimulating Tie-2.

Authors:  Laura J Braun; Rebekka I Stegmeyer; Kerstin Schäfer; Stefan Volkery; Silke M Currie; Birgit Kempe; Astrid F Nottebaum; Dietmar Vestweber
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

Review 4.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

5.  Platelets: essential components of the immune system.

Authors:  Ramadan A Ali; Leah M Wuescher; Randall G Worth
Journal:  Curr Trends Immunol       Date:  2015

Review 6.  How platelets safeguard vascular integrity.

Authors:  B Ho-Tin-Noé; M Demers; D D Wagner
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

7.  Platelet - leukocyte interactions: multiple links between inflammation, blood coagulation and vascular risk.

Authors:  Chiara Cerletti; Giovanni de Gaetano; Roberto Lorenzet
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-13       Impact factor: 2.576

8.  Blocking neutrophil diapedesis prevents hemorrhage during thrombocytopenia.

Authors:  Carina Hillgruber; Birgit Pöppelmann; Carsten Weishaupt; Annika Kathrin Steingräber; Florian Wessel; Wolfgang E Berdel; J Engelbert Gessner; Benoît Ho-Tin-Noé; Dietmar Vestweber; Tobias Goerge
Journal:  J Exp Med       Date:  2015-07-13       Impact factor: 14.307

Review 9.  The vascular endothelium and human diseases.

Authors:  Peramaiyan Rajendran; Thamaraiselvan Rengarajan; Jayakumar Thangavel; Yutaka Nishigaki; Dhanapal Sakthisekaran; Gautam Sethi; Ikuo Nishigaki
Journal:  Int J Biol Sci       Date:  2013-11-09       Impact factor: 6.580

10.  Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis.

Authors:  Li-Xin Jia; Guan-Ming Qi; Ou Liu; Tao-Tao Li; Min Yang; Wei Cui; Wen-Mei Zhang; Yong-Fen Qi; Jie Du
Journal:  Cardiovasc Drugs Ther       Date:  2013-12       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.